azelaic acid

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 68462-626
  • Package NDC 68462-626-52
  • Application number ANDA204637
  • SPL ID 28cca0c1-2f38-4fa2-8aaf-d3c8978b0fc6
  • SPL set ID 0b5ab22e-c78a-4429-9a76-a4ba2d11fcde
  • UNII F2VW3D43YT
  • RxCUI 1041518

What the source publishes

Labeler
Glenmark Pharmaceuticals Inc., USA
Active ingredients
azelaic acid
Form
GEL
Routes
TOPICAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:68462-626_28cca0c1-2f38-4fa2-8aaf-d3c8978b0fc6
{
  "name": "azelaic acid",
  "splId": "28cca0c1-2f38-4fa2-8aaf-d3c8978b0fc6",
  "labels": [
    {
      "setId": "0b5ab22e-c78a-4429-9a76-a4ba2d11fcde",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0b5ab22e-c78a-4429-9a76-a4ba2d11fcde",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=0b5ab22e-c78a-4429-9a76-a4ba2d11fcde"
    }
  ],
  "routes": [
    "TOPICAL"
  ],
  "labeler": "Glenmark Pharmaceuticals Inc., USA",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 TUBE in 1 CARTON (68462-626-52)  / 50 g in 1 TUBE",
      "package_ndc": "68462-626-52",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20181119"
    }
  ],
  "productId": "68462-626_28cca0c1-2f38-4fa2-8aaf-d3c8978b0fc6",
  "useDomain": "unknown",
  "dosageForm": "GEL",
  "productNdc": "68462-626",
  "deaSchedule": null,
  "genericName": "azelaic acid",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "AZELAIC ACID",
      "strength": ".15 g/g"
    }
  ],
  "applicationNumber": "ANDA204637",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20181119",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000008841",
      "N0000009982"
    ],
    "upc": [
      "0368462626528"
    ],
    "unii": [
      "F2VW3D43YT"
    ],
    "rxcui": [
      "1041518"
    ],
    "spl_set_id": [
      "0b5ab22e-c78a-4429-9a76-a4ba2d11fcde"
    ],
    "pharm_class_pe": [
      "Decreased Protein Synthesis [PE]",
      "Decreased Sebaceous Gland Activity [PE]"
    ],
    "manufacturer_name": [
      "Glenmark Pharmaceuticals Inc., USA"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:68462-626_28cca0c1-2f38-4fa2-8aaf-d3c8978b0fc6"